NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Agreed. Exactly right. Yes, and not to disrupt orders or production, certainly anything currently in process or about to hit production might still also stay in the current stream if they were not also acquired. It is probably a very easy acquisition in one deal though. I do not think it is a huge amount of the value, but it’s also not a huge company with a lot of other relationships at this stage. Once NWBO is fully licensed to sell DCVax and production is fully scaled, Advent might branch out to doing other products in a more committed basis and that likely would not be something worthwhile for an acquiring company. They might then take Advent in a package deal, disentangle and spin out the rest, but only if speed and convenience were paramount. I am sure it can be worked out well for the various parties. No one will likely be left disadvantaged. There is some risk for Advent and that is, as I recall, a part of their contract as well, even in a worst case scenario, but it also would apply in a good case scenario as well that they likely would not be left high and dry, as it would be expected.